Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Suparma Tbk. (SPMA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Suparma Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 1.7K 24h volume), while Suparma Tbk. trades at Rp167 (market cap 874.19B, 14.9K 24h volume). The key difference: Suparma Tbk. is far larger — about 2.7× Diagnos Laboratorium Utama Tbk.'s market cap, and Suparma Tbk. is more actively traded (14.9K versus 1.7K). Which is the better fit depends on your goals.
| DGNS | SPMA | |
|---|---|---|
Market Cap | 319B | 874.19B |
Volume | 1.7K | 14.9K |
Lot | 17 | 149 |
Turnover | 392K | 2.48M |
Average Price | 230.59 | 166.68 |
Value | 392K | 2.48M |
Indicative Equilibrium Price | 232 | — |
Indicative Equilibrium Volume | 200 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Suparma Tbk.
PT Suparma Tbk (Entity) was established under the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970 based on the Notarial Deed No. 29 of Tjahjadi Hartanto, S.H., on August 25, 1976. The Entity's name, PT Supar Inpama was changed to PT Suparma based in the Notarial Deed No. 5 dated December 7, 1978 of the same notary.
Read more on SPMA →
